Post-approval studies (Phase 4)Looking for participantsNCT06865885
What this trial is testing
LDL-C Optimization Using Inclisiran in Patients in Which Drug-Drug Interactions Limit LDL Lowering
Who this might be right for
Drug InteractionsPrimary PreventionCardiometabolic Syndrome+1 more
University of California, San Diego 100